JFS Wealth Advisors LLC Trims Position in Walgreens Boots Alliance Inc (WBA)
JFS Wealth Advisors LLC decreased its stake in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 8.3% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 21,949 shares of the pharmacy operator’s stock after selling 1,999 shares during the period. JFS Wealth Advisors LLC’s holdings in Walgreens Boots Alliance were worth $1,695,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors also recently modified their holdings of the stock. Commonwealth Bank of Australia raised its holdings in Walgreens Boots Alliance by 139.5% during the 2nd quarter. Commonwealth Bank of Australia now owns 46,167 shares of the pharmacy operator’s stock worth $3,614,000 after purchasing an additional 26,893 shares during the last quarter. IBM Retirement Fund raised its holdings in Walgreens Boots Alliance by 88.1% during the 2nd quarter. IBM Retirement Fund now owns 22,903 shares of the pharmacy operator’s stock worth $2,004,000 after purchasing an additional 10,729 shares during the last quarter. Andra AP fonden raised its holdings in Walgreens Boots Alliance by 35.3% during the 2nd quarter. Andra AP fonden now owns 58,300 shares of the pharmacy operator’s stock worth $4,565,000 after purchasing an additional 15,200 shares during the last quarter. Schwab Charles Investment Management Inc. raised its holdings in Walgreens Boots Alliance by 5.4% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 3,019,739 shares of the pharmacy operator’s stock worth $236,476,000 after purchasing an additional 154,995 shares during the last quarter. Finally, Birinyi Associates Inc. raised its holdings in Walgreens Boots Alliance by 9.0% during the 2nd quarter. Birinyi Associates Inc. now owns 9,100 shares of the pharmacy operator’s stock worth $713,000 after purchasing an additional 750 shares during the last quarter. Institutional investors and hedge funds own 61.41% of the company’s stock.
In related news, Director William C. Foote sold 2,736 shares of the stock in a transaction that occurred on Thursday, November 2nd. The stock was sold at an average price of $67.37, for a total transaction of $184,324.32. Following the completion of the sale, the director now directly owns 16,415 shares of the company’s stock, valued at approximately $1,105,878.55. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director John Anthony Lederer bought 20,000 shares of the stock in a transaction that occurred on Thursday, October 26th. The shares were acquired at an average cost of $67.00 per share, with a total value of $1,340,000.00. Following the completion of the purchase, the director now owns 50,000 shares in the company, valued at approximately $3,350,000. The disclosure for this purchase can be found here. 14.80% of the stock is currently owned by corporate insiders.
Shares of Walgreens Boots Alliance Inc (WBA) opened at $70.36 on Friday. Walgreens Boots Alliance Inc has a 52 week low of $63.82 and a 52 week high of $88.00. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.07 and a quick ratio of 0.59. The company has a market capitalization of $71,315.52, a PE ratio of 14.12, a PEG ratio of 1.28 and a beta of 1.22.
Walgreens Boots Alliance (NASDAQ:WBA) last posted its earnings results on Wednesday, October 25th. The pharmacy operator reported $1.31 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.21 by $0.10. Walgreens Boots Alliance had a return on equity of 18.36% and a net margin of 3.45%. The business had revenue of $30.15 billion during the quarter, compared to analysts’ expectations of $29.93 billion. During the same period in the prior year, the business earned $1.07 EPS. Walgreens Boots Alliance’s revenue for the quarter was up 5.3% compared to the same quarter last year. sell-side analysts predict that Walgreens Boots Alliance Inc will post 5.54 earnings per share for the current year.
Walgreens Boots Alliance declared that its board has authorized a share repurchase program on Wednesday, October 25th that permits the company to buyback $1.00 billion in shares. This buyback authorization permits the pharmacy operator to buy shares of its stock through open market purchases. Shares buyback programs are generally an indication that the company’s leadership believes its stock is undervalued.
The firm also recently announced a quarterly dividend, which was paid on Tuesday, December 12th. Investors of record on Monday, November 13th were paid a dividend of $0.40 per share. The ex-dividend date was Friday, November 10th. This represents a $1.60 dividend on an annualized basis and a yield of 2.27%. Walgreens Boots Alliance’s payout ratio is 42.33%.
Several analysts have weighed in on WBA shares. UBS reissued a “buy” rating and set a $96.00 price objective (down from $97.00) on shares of Walgreens Boots Alliance in a report on Wednesday, August 23rd. Loop Capital started coverage on Walgreens Boots Alliance in a report on Thursday, August 24th. They set a “buy” rating and a $95.00 price objective for the company. BidaskClub raised Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a report on Wednesday, August 30th. Jefferies Group reaffirmed a “buy” rating and issued a $95.00 price target on shares of Walgreens Boots Alliance in a research note on Thursday, September 7th. Finally, Needham & Company LLC reaffirmed a “buy” rating and issued a $94.00 price target on shares of Walgreens Boots Alliance in a research note on Sunday, September 10th. One analyst has rated the stock with a sell rating, nine have assigned a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the stock. Walgreens Boots Alliance has an average rating of “Buy” and a consensus target price of $86.47.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.